A method of detecting tissue oedema in a subject. The method includes determining a measured impedance for first and second body segments. An index indicative of a ratio of the extra-cellular to intra-cellular fluid is then calculated for each body segment, with these being used to determine an index ratio based on the index for the first and second body segments. The index ratio can in turn be used to determine the presence, absence or degree of tissue oedema, for example by comparing the index ratio to a reference or previously determined index ratios.

Patent
   8615292
Priority
Jun 18 2004
Filed
Jun 17 2005
Issued
Dec 24 2013
Expiry
May 03 2029
Extension
1416 days
Assg.orig
Entity
unknown
0
198
EXPIRED
1. A method of detecting tissue oedema in a subject, the method comprising:
a) determining a measured impedance for a first body segment;
b) determining a measured impedance for a second body segment, the second body segment being different from the first body segment;
c) for each body segment, and using the respective measured impedance, determining, using a processor of a processing system, an index indicative of a ratio of the extra-cellular to intra-cellular fluid;
d) determining, using the processor of the processing system, an index ratio based on the index for the first and second body segments; and
e) determining the presence, absence or degree of tissue oedema based on the index ratio.
2. A method according to claim 1, wherein the method includes, in the processing system:
a) comparing the index ratio to at least one reference; and
b) determining the presence, absence or degree of tissue oedema based on the results of the comparison.
3. A method according to claim 2, wherein the reference includes at least one of:
a) a predetermined threshold;
b) a tolerance determined from a normal population; and
c) a predetermined range.
4. A method according to claim 2, wherein the reference includes an index ratio previously determined for the subject.
5. A method according to claim 4, wherein the previously determined index ratio is determined prior to the subject undergoing at least one of:
a) surgery; and
b) treatment.
6. A method according to claim 1, wherein the first and second body segments are different types of body segments.
7. A method according to claim 1, wherein the first and second body segments are limbs.
8. A method according to claim 1, wherein the first body segment is a leg and the second body segment is an arm.
9. A method according to claim 1, wherein the method includes, in the processing system:
a) determining a plurality of measured impedances for each body segment, each measured impedance being measured at a corresponding measurement frequency; and,
b) determining the index ratio based on the plurality of measured impedances.
10. A method according to claim 9, wherein the method includes, in the processing system:
a) determining values for parameters R0 and R from the measured impedance values; and,
b) calculating the index (I) using the equation:
e####
I = R R 0 - R
where: R0 is the resistance at zero frequency;
and, R is the resistance at infinite frequency.
11. A method according to claim 10, wherein the method includes, in the processing system, determining the parameter values using the equation:
Z = R + R 0 - R 1 + ( j ω τ ) ( 1 - α )
where:
Z is the measured impedance at angular frequency ω,
τ is a time constant,
and α has a value between 0 and 1.
12. A method according to claim 11, wherein the method includes, in the processing system:
a) determining the impedance of each body segment at four discrete frequencies; and,
b) determining values for the parameters by solving the equation using four simultaneous equations.
13. A method according to claim 10, wherein the method includes, in the processing system, determining the parameter values by:
a) determining an impedance locus using the measured impedance values; and
b) using the impedance locus to determine the parameter values.
14. A method according to claim 1, wherein the method includes, in the processing system, displaying an indication of at least one of:
a) the parameter values;
b) the ratio of extra-cellular to intra-cellular fluid; and,
c) an indication of the at least one of the presence, absence or degree of tissue oedema in the subject.
15. A method according to claim 1, wherein the processing system is coupled to an apparatus comprising:
a) a current supply for generating an alternating current at each of a plurality of frequencies;
b) at least two supply electrodes for applying the generated alternating current to a subject;
c) at least two measurement electrodes for detecting a voltage across the subject; and,
d) a sensor coupled to the measurement electrodes for determining the voltage, the sensor being coupled to the processing system to thereby allow the processing system to determine the measured impedances.

This application is a U.S. National Phase under 35 USC §371 of the International Application No.: PCT/AU2005/000876, filed on Jun. 17, 2005, designating the U.S. and published in English on Dec. 15, 2005 as WO/2005/122888, which claims the benefit of priority of Australian Application No. 2004903314, filed on Jun. 18, 2004, each of which is incorporated by reference.

The present invention relates to a method and apparatus for detecting tissue oedema, and in particular, to a method and apparatus for detecting tissue oedema using impedance measurements.

The reference to any prior art in this specification is not, and should not be taken as, an acknowledgment or any form of suggestion that the prior art forms part of the common general knowledge.

Lymphoedema is a condition characterised by excess protein and oedema in the tissues as a result of reduced lymphatic transport capacity and/or reduced tissue proteolytic capacity in the presence of a normal lymphatic load. Acquired, or secondary lymphoedema, is caused by damaged or blocked lymphatic vessels. “The commonest inciting events are surgery and/or radiotherapy. However, onset of lymphoedema is unpredictable and may develop within days of its cause or at any time during a period of many years after that cause.

WO00/79255 describes a method of detection of oedema by measuring bioelectrical impedance at two different anatomical regions in the same subject at a single low frequency alternating current. The two measurements are analysed to obtain an indication of the presence of tissue oedema by comparing with data obtained from a normal population.

Other known methods of analysis of bioelectrical impedance measurements involve determining a phase and amplitude value for the measured signals. The measurement of amplitude is straightforward but the measurement of phase is more complicated and therefore the required equipment is costly.

In a first broad form the present invention provides a method of detecting tissue oedema in a subject, the method including, in a processing system:

Typically the method includes, in the processing system:

Typically the reference includes at least one of:

Typically the reference includes an index ratio previously determined for the subject.

Typically the previously determined index ratio is determined prior to the subject undergoing at least one of:

Typically the first and second body segments are different types of body segment.

Typically the first and second body segments are limbs.

Typically the first body segment is a leg and the second body segment is an arm.

Typically the method includes, in the processing system:

Typically the method includes, in the processing system:

I = R R 0 - R

Typically the method includes, in the processing system, determining the parameter values using the equation:

Z = R + R 0 - R 1 + ( j ω τ ) ( 1 - α )

Typically the method includes, in the processing system:

Typically the method includes, in the processing system, determining the parameter values by:

Typically the method includes, in the computer system, displaying an indication of at least one of:

In a second broad form the present invention provides apparatus for detecting tissue oedema in a subject, the apparatus including a processing system for:

Typically the apparatus includes:

Typically the apparatus is adapted to perform the method of the first broad form of the invention.

In a third broad form the present invention provides a method of diagnosing tissue oedema in a body region, the method including:

Z = R + R 0 - R 1 + ( j ω τ ) ( 1 - α )
to obtain parameters R0, R, τ and α,

Typically the method includes diagnosing tissue oedema by determining the presence, absence or degree of tissue oedema.

Typically the method includes:

Typically the method includes:

Typically the method includes:

Typically the method includes:

R i = R R e R e - R ; and

Typically the method includes indicating tissue oedema by displaying the indication as a position on a scale.

Typically the method is a method according to the first broad form of the invention.

In a fourth broad form the present invention provides apparatus for detecting tissue oedema, the apparatus including:

Z = R + R 0 - R 1 + ( j ω τ ) ( 1 - α )
to obtain parameters R0, R, τ and α,

Typically the current supply includes a proximal electrode and distal electrode in electrical correction with a power source.

Typically the monitor includes a first connection and second connection for location on or near the anatomical region.

Typically the monitor includes display means to display the signals indicative of bioimpedance.

Typically the processing system is suitably programmed to perform analysis of data to provide an indication of the presence of tissue oedema.

Typically the apparatus is adapted to perform the method of the third broad form of the invention.

In a fifth broad form the present invention provides a method of diagnosing tissue oedema in a body region, the method including:

R i = R R e R e - R ; and

Typically the method includes:

Typically the method is a method according to the first or third broad forms of the invention.

In a sixth broad form the present invention provides apparatus for diagnosing tissue oedema in a body region, the apparatus including a processing system for:

R i = R R e R e - R ; and

Typically the apparatus is adapted to perform the method of the fifth broad form of the invention.

An example of the present invention will now be described with reference to the accompanying drawings, in which: —

FIG. 1 is a schematic of an example of a theoretical equivalent circuit for biological tissue;

FIG. 2 is an example of a locus of impedance known as a Cole-Cole plot;

FIG. 3 is a schematic of an example of a single channel bioimpedance apparatus;

FIG. 4 is a schematic of an example of a dual channel bioimpedance apparatus; and,

FIG. 5 is a flow chart of an example of a process for evaluating tissue oedema.

FIG. 1 is an example of an equivalent circuit that effectively models the electrical behaviour of biological tissue. The equivalent circuit has two branches that represent current flow through extracellular fluid and intracellular fluid. The extracellular component of biological impedance is represented by Re and the intracellular component is represented by Ri. Capacitance of the cell membrane in the intracellular path is represented by C.

The relative magnitudes of the extracellular and intracellular components of impedance of an alternating current (AC) are frequency dependent. At zero frequency the capacitor acts as a perfect insulator and all current flows through the extracellular fluid, hence the resistance at zero frequency, R0, equals Re. At infinite frequency the capacitor acts as a perfect conductor and the current passes through the parallel resistive combination. The resistance at infinite frequency is given by R=RiRe/(Ri+Re). The measured values of R0 and R would therefore directly provide the values of Re and Ri. required for estimation of extracellular water (ECW) and intracellular water (ICW), which lead to identification of oedema by comparison between affected and unaffected body regions. However, as is well known, the practical constraints of skin-electrode impedance do not permit application of DC or very high frequency AC currents, hence the values of the frequencies commonly used can only approximate the ideal measurement frequencies.

The impedance of the equivalent circuit of FIG. 1 at an angular frequency ω, where ω=2π*frequency, is given by:

Z = R + R 0 - R 1 + ( j ω τ ) ( 1 )
where:

These values can be estimated by extrapolating what is known as a Cole-Cole plot, which is a plot of the vector sum of the resistance R and reactance X that sum to impedance Z. A Cole-Cole plot of reactance against resistance is shown in FIG. 2 with an impedance vector Z at a given frequency.

It is also known that biological specimens deviate from the equivalent circuit because the cell membrane is an imperfect capacitor and there is a large variation between cell types in the current path. This results in a Cole-Cole plot of a biological specimen having a depressed centre compared to the equivalent circuit plot shown in FIG. 2. A more accurate expression for impedance in a biological sample is therefore given by:

Z = R + R 0 - R 1 + ( j ω τ ) ( 1 - α ) ( 2 )
where α has a value between 0 and 1 and can be thought of as an indicator of the deviation of a real system from the ideal model.

Another important value is the impedance Zc at the peak of the locus in FIG. 2. This peak occurs when ω=1/τ which is referred to as the characteristic angular frequency, ωc which equals 2πfc.

As explained above, the prior art approach to determining the desired values of R0 and R has been to make impedance measurements at multiple frequencies and to construct a section of a Cole-Cole plot. The plot can be extrapolated to determine R0, R and Zc. This procedure takes a significant amount of processing time and therefore makes real time monitoring of bioimpedance problematic. Furthermore, the measurements require determination of both phase and amplitude values which require relatively sophisticated, and therefore expensive, equipment.

Equation (2) has four, unknowns, R0, R and α. The values of these unknowns can be determined by taking measurements at four discrete frequencies, and solving four simultaneous equations. Any of the established methods such as matrix inversion or numerical iteration can be used to solve the equations for the unknown values.

The values determined by this process compare favourably with the values obtained by the conventional curve fitting technique, in which measured impedances are used to plot a locus similar to that shown in FIG. 2, thereby allowing values of R0 and R to be obtained.

Greater, accuracy can be achieved by taking measurements at a larger number of frequencies, albeit at a cost in processing overhead. Furthermore, accurate results can usefully be derived by selecting discrete frequencies that span the range of frequencies normally used in multiple frequency bioelectrical impedance analysis (51 KHz to 1000 KHz).

Once the values of R0, R and Zc are determined they can be used in various ways to detect and quantify oedema in a body region. One approach to this quantification is to compare measurements taken at a first body region against measurements taken at a second body region.

The second measurements may be taken in a paired unaffected body region. For example, a first measurement may be made at a location on the left leg and a second measurement made at the same location on the right leg of the same patient where the right leg is unaffected by tissue oedema. It is clear to a skilled addressee that other paired anatomical regions may be similarly used when performing the above described methodology. For example, paired areas of the thorax may be assessed.

It is, however, possible to take the second measurement at a dissimilar body region. For example, the first reading may be taken on a leg, and a second reading may be taken on an arm. The analysis of these readings will necessarily involve some different considerations. Again, it is clear to a skilled addressee that a wide range of dissimilar anatomical structures may be used for these measurements, such as a leg and the chest wall. This form of the method is of particular use where two paired anatomical sites are both affected by tissue oedema. The comparison of readings taken in two such affected sites will be distorted and will not produce a reliable indicator of tissue oedema.

As a further alternative, the method may be applied to two or more measurements on the same anatomical region of a subject where those readings are separated in time. For example, a series of readings may be taken on a single limb prior to and subsequent to surgery with a known risk of lymphoedema as a side effect. Analysis of any two or more readings may indicate the early stage of developing lymphoedema and thereby provide a distinct advantage in that the prognosis may be greatly improved by early and aggressive therapeutic intervention. This technique may also be used to monitor the progress of oedema with comparison made between measurements of an affected site.

In the case of comparison of any two dissimilar regions it is known that a correcting factor may be required. A correcting factor may be established by surveying a population of clinically unaffected subjects:

Another approach is a modification of the technique described in a publication, (Cornish, B. H.; Thomas B. J.; Ward L. C.; Angiology Vol 53, No 1, pp 41-47 2002). In this approach the measured parameters are used to calculate an index Ri/Re. as indicative of the ratio of extracellular fluid to intracellular fluid. The extracellular fluid resistance Re is determined from
Re=R0
and intracellular fluid resistance Ri is determined from

R i = R R e R e - R .

Thus, the index I, which is indicative of the ratio of extra- to intra-cellular fluid is given by the equation:

I = R i R e = R R 0 - R ( 3 )

This approach has particular application to monitoring oedema overtime as a plot of the index against time can disclose the onset and rate of advance of oedema.

Referring to FIG. 3, there is shown a schematic of an apparatus for measuring impedance, including an oscillator 20, divider 21 and filter 22 connected in series to produce alternating current at a number of discrete frequencies when connected to a power, source (not shown). The alternating current passes through cable 23 to electrode 24 through intervening tissue (not shown) to electrode 25, which is connected to a reference 26 via cable 27.

Monitoring electrodes 28, 29 are in connection with bioimpedance measuring meter 30 via cables 31, 32. Signals from bioimpedance measuring meter 30 are passed to analogue/digital converter 33, which is in signal connection with data storing unit 34, which retains the digitised reading of bioimpedance.

The applied signal is suitably derived from a constant current source to ensure that the generated current does not exceed the Australian Standard of a maximum of 32V and a maximum current of 100 μA at 10 kHz. The current limit increases to an upper threshold of 1 mA at 1000 kHz. The applied signal could be derived from a constant voltage source rather than a constant current source providing a mechanism is provided to maintain the safety standard.

A first reading of bioelectrical impedance is taken from a first anatomical region of a subject and stored in data storing unit 34.

The processor 35 calculates the values R0, R, τ and α by solving the equation (2) and transfers the result to second data storing unit 36. The values may also be presented on display 37.

The processor may also calculate an indicator of oedema, such as the Ri/Re index, and display this on a scale with a movable indicator. There may also be a simple series of lights which, when illuminated, indicate any one of “unaffected”, “possibly affected” or “affected”. The display may be any other suitable form of indicator.

It is more convenient for many of the techniques for assessing oedema to use a two-channel bioimpedance meter as shown in FIG. 4. In this case, current is passed between the electrodes 24, 25 on, for example, one arm 47 and between the electrodes 24A, 25A on the opposite arm 48. This can be achieved either sequentially, for example through the use of multiplexing, or simultaneously. Monitoring electrodes 28, 29 on the first arm 47 measure bioelectrical impedance while monitoring electrodes 28A, 29A measure bioelectrical impedance on the opposite arm 48. A measuring meter 30 has two channels for simultaneously monitoring signals provided from the monitoring electrodes 28, 29; 28A; 29A. The signals are passed through an analogue/digital converter 33 and then analysed by processor 35. The results are stored in memory 36 and shown on display 37.

Accordingly the processor 35 operates to analyse the impedance signals and use this to provide an evaluation of the presence, absence or degree of tissue oedema. This is typically performed in accordance with applications software provided in the memory. It will be appreciated from this that the processor 35, the memory 36 and the display 37 may typically be formed from a processing system, such as a computer system, computer server, desktop computer, lap-top, specialised hardware, or the like.

An example of the process for monitoring the impedance signals and evaluating tissue oedema will now be described with reference to the flowchart shown in FIG. 5.

In particular, at step 600, the impedance at first and second body segments are measured using the apparatus shown in FIG. 4. In this example, the body segments are different body segments and may include for example an arm and a leg.

At step 610 the processor 35 determines values of R0 and R for each body segment. This can be achieved using a number of mechanisms. For example, given that there are four unknown parameters R0, R, τ, α, the equation (2) can be used to determine four simultaneous equations, which can then be solved using appropriate mathematical techniques. Alternatively, the measured impedance values can be plotted to derive an arc similar to that shown in FIG. 2, which then further allows the values of R0 and R to be determined. Alternative techniques may also be used.

At step 620 the values of R0 and R are used to determine an index I for each body segment. The index is based on the ratio of the extracellular to intracellular fluid and is therefore calculated using equation (3).

At step 630 an index ratio IR based on a ratio of the first body segment index I1 to second body segment index I2 is calculated, with this being used in evaluating the presence, absence or degree of oedema.

This is possible, as, for a healthy subject, there is generally a degree of similarity of intra- and extra-cellular fluid levels, even between different body segments. Thus, for example, if the subject is suffering from a condition other than oedema, which causes a general change in the ratio of extra- to intra-cellular fluid, then this should affect all body segments roughly equally. As a result, assuming that neither body segment has tissue oedema, then the index ratio IR should remain relatively constant for a given individual.

It will be appreciated that in the event that the properties of each body segment are equal, then the index ratio should have a value in the region of 1. Typically however, minor variations in tissue will occur between different body segments, and this can be accounted for in one of two ways.

Firstly, as shown at step 640, the index ratio IR can be compared to a predetermined range. In this case, the range is used to account for variations between body segments that are not attributable to tissue oedema. It will therefore be appreciated that the range is therefore typically set to take into account the difference in index ratio IR between different body portions in a number of different subjects. This range can therefore be set based on data collected from a number of healthy subjects.

In any event, if the index ratio IR falls outside the predetermined range, then this is used by the processor 35 to determine that tissue oedema is present in one of the body segments at step 650.

Furthermore, an assessment of the value of the index ratio IR can be used in assessing the degree of tissue oedema. Thus, for example, a number of value ranges can be defined, with each range corresponding to a different degree of oedema. In this instance, the processor 35 determines within which range the index ratio IR falls, and uses this to generate an indication of the likely degree of tissue oedema.

The value of the index ratio IR will also depend on the body segments that have been selected and accordingly, in general a different range will be selected for the comparison depending on the body segments under consideration.

It will also be appreciated that the index ratio IR can be used to indicate in which body segment the oedema is present, and this can be based on whether the index ratio IR is greater than or less than 1.

The index ratio IR may also depend on a number of factors, such as the subject's age, weight, sex and height, and again a respective range can be selected based on these factors. However, to avoid the need for an assessment of such factors, an alternative process of longitudinal analysis can be performed.

In this case, at step 660 the processor 35 can compare the index ratio IR to previously determined index ratios IRprev measured for the same subject, on the same body segments. In this situation, the previously determined index ratios IRprev are preferably determined prior to the onset of oedema but this is not essential.

In any event, previous measurements of the same body segments on the same subject will automatically account for inherent variations in tissue properties, which in turn cause different values for the ratio of extra- to intra-cellular fluid even if tissue oedema is not present.

In this case, the processor 35 assesses whether the current index ratio IR value is different to the previous index ratio IRprev. If there is change in the value, then the direction in change in value can indicate either increasing or decreasing levels of tissue oedema, with the magnitude of the change being used to indicate a degree of change at step 650.

In general, at step 650, the display 37 is used to display an indication of one or more of:

It will therefore be appreciated from this that the above-described methodology provides two different methods of determining the onset for oedema. This can be achieved either by performing a longitudinal analysis in which the index ratio IR is compared to previously determined index ratios IRprev. Alternatively the index ratio IR can be compared to one or more absolute index ratio ranges.

In practice, a combination for the two approaches will generally be used. Thus, for example, when a patient is first admitted for a procedure to be performed, a comparison to absolute index ratio ranges may be used to confirm that it is unlikely that the patient has oedema.

The measured index ratio IR can then be used to form the reference value of the index ratio IRprev, allowing subsequent measurements to be compared thereto.

By using the index ratio IR described above, this allows variation in tissue properties between different body portions to be taken into account when assessing the presence, absence or degree of tissue oedema, and accordingly, this allows the onset of bilateral oedema to be detected. This is in contrast to previous techniques, in which like body segments are compared. In this case, if impedance measurements of a limb, such as a leg, are compared to measurements from the other corresponding limb, then in the event that oedema is present in both limbs, the impedance measurements will be similar, and will not therefore indicate that oedema is present.

As mentioned above, the values of R0 and R can be determined in any one of a number of ways. However, in general it is preferred to be able to determine the values in real-time to thereby vastly enhance the oedema assessment process. In particular, this allows measurements to be made of the patient, with the processor 35 generating an indication of the degree of tissue oedema in real-time.

The discussion has referred to both oedema and lymphoedema, as it is clear to a skilled addressee that the above method and apparatus may be utilised on any form of tissue oedema. However, it is also likely that the predominant use of the method, and apparatus will be directed mainly to lymphoedema due to its clinical relevance. However, this may change in a specific situation or with time. The method may also be used in comparing a reading from one anatomical region with a separate unpaired region. For example, a reading taken on central localised oedema (eg: ascites) may be referenced against a nonoedematous structure such as a limb.

Throughout the specification, the aim has been to describe the preferred embodiments of the invention without limiting the invention to any one embodiment or specific collection of features. Various changes and modifications may be made to the embodiments described and illustrated without departing from the present invention.

Ward, Leigh, Cornish, Bruce

Patent Priority Assignee Title
Patent Priority Assignee Title
3316896,
3851641,
3871359,
4008712, Nov 14 1975 R J L SYSTEMS, INC Method for monitoring body characteristics
4034854, Jul 16 1976 M I Systems, Inc. Electrode package
4144878, Jun 19 1974 Johnson & Johnson Professional, Inc Occlusive impedance phlebograph and method therefor
4184486, Aug 11 1977 LICENCIA TALALMANYOKAT ERTEKESITO ES INNOVACIOS KULKERESKEDELMI VALLAT Diagnostic method and sensor device for detecting lesions in body tissues
4291708, Nov 02 1977 TRANSSCAN MEDICAL LTD Apparatus and method for detection of tumors in tissue
4314563, Sep 24 1970 The United States of America as represented by the Administrator of the Apparatus for measuring relative changes in blood volume in a portion of an animal body to detect a venous occlusion
4365634, Dec 06 1979 C. R. Bard, Inc. Medical electrode construction
4407288, Dec 11 1980 MIROWSKI FAMILY VENTURES L L C Implantable heart stimulator and stimulation method
4407300, Jul 14 1980 Potentiometric diagnosis of cancer in vivo
4450527, Jun 29 1982 Cardiodynamics International Corporation Noninvasive continuous cardiac output monitor
4458694, Nov 02 1978 Yeda Research & Development Co., Ltd. Apparatus and method for detection of tumors in tissue
4468832, Jun 24 1983 LIBMAN COMPANY, THE Refill sponge mop assembly
4486835, May 13 1981 Yeda Research and Development Co. Ltd. Apparatus and techniques for electric tomography
4537203, Oct 21 1980 Tokyo Shibaura Denki Kabushiki Kaisha Abnormal cell detecting device
4539640, Jan 12 1982 TASC LTD Reconstruction system and methods for impedance imaging
4557271, May 11 1983 Method and apparatus for detecting body illness, dysfunction, disease and/or pathology
4583549, May 30 1984 ECG electrode pad
4602338, Sep 02 1982 British Telecommunications Impedance measurement in 4-wire to 2-wire converters
4617939, Apr 30 1982 FLEET NATIONAL BANK, AS AGENT Tomography
4646754, Feb 19 1985 Non-invasive determination of mechanical characteristics in the body
4686477, Sep 30 1985 Mobil Oil Corporation Multiple frequency electric excitation method and identifying complex lithologies of subsurface formations
4688580, Jul 11 1985 The Johns Hopkins University Non-invasive electromagnetic technique for monitoring bone healing and bone fracture localization
4763660, Dec 10 1985 AURORA CAPITAL MANAGEMENT, L L C Flexible and disposable electrode belt device
4793362, Apr 22 1982 Karolinska Institutet Method and apparatus for monitoring the fluid balance of the body
4895163, May 24 1988 Bio Analogics, Inc. System for body impedance data acquisition
4911175, Sep 17 1987 LIEDTKE, RUDOLPH J ; TWYMAN, DIANA Method for measuring total body cell mass and total extracellular mass by bioelectrical resistance and reactance
4942880, Jan 28 1982 Ceske vysoke uceni technicke v Praze Method for non-invasive electric diagnosis and therapy in hemodialysis and general medicine
4951682, Jun 22 1988 The Cleveland Clinic Foundation Continuous cardiac output by impedance measurements in the heart
5025784, Sep 05 1987 Harbin Polytechnic University Apparatus and method for detecting and processing impedance rheogram
5063937, Sep 12 1990 Wright State University Multiple frequency bio-impedance measurement system
5143079, Aug 02 1989 Yeda Research and Development Company Limited Apparatus for detection of tumors in tissue
5197479, May 13 1991 Mortara Instrument Automatic electrode channel impedance measurement system for egg monitor
5246008, Jan 11 1991 CARDIOTECHNICA GMBH Method for monitoring a patient for rejection reactions to an implanted heart
5280429, Apr 30 1991 XITRON TECHNOLOGIES A CA CORPORATION Method and apparatus for displaying multi-frequency bio-impedance
5311878, Jun 13 1990 British Technology Group Limited Real-time electrical impedance tomography system
5372141, Jul 01 1992 NUTRITION SOLUTIONS CORPORATION, THE Body composition analyzer
5415164, Nov 04 1991 Biofield Corp Apparatus and method for screening and diagnosing trauma or disease in body tissues
5449000, May 24 1988 ABC Development System for body impedance data acquisition utilizing segmental impedance & multiple frequency impedance
5465730, Jul 26 1991 British Technology Group Ltd. Electrical impedance tomography
5469859, Jun 24 1992 N.I. Medical Ltd. Non-invasive method and device for collecting measurements representing body activity and determining cardiorespiratory parameters of the human body based upon the measurements collected
5503157, Mar 17 1995 HEMO SAPIENS, INC System for detection of electrical bioimpedance signals
5505209, Jul 07 1994 Intellectual Property, LLC Impedance cardiograph apparatus and method
5529072, Mar 17 1995 HEMO SAPIENS, INC System for detection of electrical bioimpedance signals
5544662, Jul 09 1991 Rensselaer Polytechnic Institute High-speed electric tomography
5588429, Jul 09 1991 Rensselaer Polytechnic Institute Process for producing optimal current patterns for electrical impedance tomography
5704355, Jul 01 1994 Interstitial, LLC Non-invasive system for breast cancer detection
5732710, Aug 09 1996 R.S. Medical Monitoring Ltd. Method and device for stable impedance plethysmography
5746214, Oct 30 1992 British Technology Group Limited Investigation of a body
5759159, Sep 25 1996 Ormco Corporation Method and apparatus for apical detection with complex impedance measurement
5788643, Apr 22 1997 Koninklijke Philips Electronics N V Process for monitoring patients with chronic congestive heart failure
5800350, Nov 01 1993 Polartechnics, Limited Apparatus for tissue type recognition
5807251, Mar 11 1994 BTG International Limited Electrical impedance tomography
5807270, Jun 20 1994 Natus Medical Incorporated Brain damage monitor
5807272, Oct 30 1996 WORCESTER POLYTECHNIC Impedance spectroscopy system for ischemia monitoring and detection
5810742, Oct 24 1994 MIRABEL MEDICAL SYSTEMS LTD Tissue characterization based on impedance images and on impedance measurements
5919142, Jun 22 1995 BTG International Limited Electrical impedance tomography method and apparatus
6011992, May 09 1996 Church of Spiritual Technology System for measuring and indicating changes in the resistance of a living body
6015389, Dec 06 1995 BTG International Limited Impedance pneumography
6018677, Nov 25 1997 Tectrix Fitness Equipment, Inc.; Tectrix Fitness Equipment Heart rate monitor and method
6122544, May 01 1998 IMPEDIMENT LIMITED; Impedimed Limited Electrical impedance method and apparatus for detecting and diagnosing diseases
6125297, Feb 06 1998 The United States of America as represented by the United States Body fluids monitor
6142949, Nov 24 1998 Ortivus AB Lead protection and identification system
6151523, Mar 06 1997 NTE-SENER, S A Apparatus and procedure for measuring volumes and global and segmental corporal composition in human beings
6173003, Mar 26 1998 THE BANK OF NEW YORK MELLON, AS ADMINISTRATIVE AGENT Dither noise source with notched frequency spectrum
6228022, Oct 28 1998 Warsaw Orthopedic, Inc Methods and instruments for spinal surgery
6233473, Feb 16 1999 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Determining body composition using fan beam dual-energy x-ray absorptiometry
6236886, Dec 11 1996 Technology Commercialization International Method for producing a tomographic image of the body and electric impedance tomograph
6256532, Jul 29 1999 BioSpace Co., Ltd. Apparatus for analyzing body composition based on bioelectrical impedance analysis and method thereof
6292690, Jan 12 2000 Measurement Ltd Apparatus and method for measuring bioelectric impedance
6339722, Sep 26 1995 A. J. van Liebergen Holding B.V. Apparatus for the in-vivo non-invasive measurement of a biological parameter concerning a bodily fluid of a person or animal
6354996, Apr 15 1998 Braun GmbH Body composition analyzer with trend display
6496725, Dec 28 1999 Tanita Corporation Apparatus for determining degree of restoration of diseased part
6532384, Sep 03 1999 Tanita Corporation Bioelectrical impedence measuring method and body composition measuring apparatus
6569160, Jul 07 2000 Biosense, Inc System and method for detecting electrode-tissue contact
6584348, May 31 2000 GIVEN IMAGING LTD. Method for measurement of electrical characteristics of tissue
6618616, Jun 30 2000 Tanita Corporation Bioelectrical impedance measuring apparatus
6625487, Jul 17 2001 Koninklijke Philips Electronics N V Bioelectrical impedance ECG measurement and defibrillator implementing same
6631292, Mar 23 2001 JEFFERIES FINANCE LLC Bio-electrical impedance analyzer
6633777, Jul 06 1998 ALEKSANDER PASTOR Apparatus for evaluation of skin impedance variations
6643543, Aug 01 2000 Tanita Corporation Body water amount condition judging apparatus by multi-frequency bioelectric impedance measurement
6714813, Jan 21 2000 Tanita Corporation Method for measuring the degree of edema and apparatus using the same
6714814, Mar 30 2000 Tanita Corporation Bioelectrical impedance measuring apparatus
6723049, Jun 15 2001 TRUSCREEN PTY LIMITED Apparatus for tissue type recognition using multiple measurement techniques
6724200, Aug 26 1999 Tanita Corporation Apparatus for measuring the bioelectrical impedance of a living body
6760617, Jun 22 2000 The University of Queensland; Queensland University of Technology Method and device for measuring tissue oedema
6768921, Dec 28 2000 IMPEDIMENT LIMITED; Impedimed Limited Electrical impedance method and apparatus for detecting and diagnosing diseases
6845264, Oct 08 1998 Apparatus for recognizing tissue types
6870109, Jun 29 2001 Cadwell Industries, Inc. System and device for reducing signal interference in patient monitoring systems
6906533, Apr 17 2002 Funai Elec. Co. Ltd. TV remote control unit with body fat measurement function
6922586, May 20 2002 Epi-Sci, LLC Method and system for detecting electrophysiological changes in pre-cancerous and cancerous tissue
7130680, May 02 2003 Tanita Corporation Body composition measurement apparatus
7148701, Jan 08 2004 KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY KAIST Apparatus for measuring electrical impedance
7212852, Nov 27 2002 IMPEDIMENT LIMITED; Impedimed Limited Bioimpedance measurement using controller-switched current injection and multiplexer selected electrode connection
7457660, Nov 27 2002 IMPEDIMENT LIMITED; Impedimed Limited Eliminating interface artifact errors in bioimpedance measurements
7477937, Jun 30 2000 Tanita Corporation Bioelectrical impedance measuring apparatus
7706872, Dec 06 2002 Tallinn Technical University Method and device for measurement of electrical bioimpedance
20010007056,
20010020138,
20010025139,
20020020138,
20020072686,
20020079910,
20020093992,
20020123694,
20020161311,
20020194419,
20030004403,
20030050570,
20030073916,
20030105411,
20030120170,
20040015095,
20040019292,
20040077944,
20040158167,
20040167423,
20040181164,
20040186392,
20040210150,
20040210158,
20040252870,
20050033281,
20050039763,
20050098343,
20050101875,
20050137480,
20050151545,
20050177062,
20050192488,
20050203435,
20050261743,
20060004300,
20060085048,
20060085049,
20060116599,
20060122523,
20060122540,
20060224079,
20060264775,
20060270942,
20070027402,
20080002873,
20080009757,
20080039700,
20080205717,
20090043222,
20090177099,
CA2231038,
DE2912349,
EP249823,
EP357309,
EP869360,
EP1114610,
EP1146344,
EP1177760,
EP1219937,
EP1338246,
EP1452131,
EP349043,
EP377887,
EP865763,
FR2486386,
GB2131558,
GB2260416,
JP10000185,
JP10014898,
JP10014899,
JP10225521,
JP11070090,
JP2000139867,
JP2001321352,
JP2002330938,
JP9051884,
JP9220209,
WO40955,
WO79255,
WO150954,
WO167098,
WO2062214,
WO2094096,
WO4000115,
WO2004026136,
WO2004047635,
WO2004049936,
WO2004083804,
WO2005010640,
WO2005018432,
WO2005027717,
WO2005051194,
WO8807392,
WO9612439,
WO9632652,
WO9711638,
WO9823204,
WO9833553,
/
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jun 17 2005Impedimed Limited(assignment on the face of the patent)
Date Maintenance Fee Events


Date Maintenance Schedule
Dec 24 20164 years fee payment window open
Jun 24 20176 months grace period start (w surcharge)
Dec 24 2017patent expiry (for year 4)
Dec 24 20192 years to revive unintentionally abandoned end. (for year 4)
Dec 24 20208 years fee payment window open
Jun 24 20216 months grace period start (w surcharge)
Dec 24 2021patent expiry (for year 8)
Dec 24 20232 years to revive unintentionally abandoned end. (for year 8)
Dec 24 202412 years fee payment window open
Jun 24 20256 months grace period start (w surcharge)
Dec 24 2025patent expiry (for year 12)
Dec 24 20272 years to revive unintentionally abandoned end. (for year 12)